Form 4: Universal Corp Director Sells Shares Under 10b5-1 Plan

Universal Corp Director Lennart R. Freeman sold 3,746 shares of common stock at a weighted average price of $53.4514 per share.

Summary

• Lennart R. Freeman, a Director of Universal Corp /VA/ (UVV), reported a sale of common stock.
• The transaction involved the disposition of 3,746 shares of common stock.
• The shares were sold on February 19, 2026, at a weighted average price of $53.4514 per share.
• The sale was executed pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following the transaction, Mr. Freeman beneficially owns 15,993 shares, which includes 2,290 restricted stock units and 70 dividend equivalent units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While insider selling can sometimes be a negative signal, this transaction was executed under a Rule 10b5-1 plan, suggesting it's part of a pre-scheduled financial strategy rather than a reaction to new information.

Negatives

• A director, Lennart R. Freeman, sold 3,746 shares of common stock. While executed under a Rule 10b5-1 plan, insider selling can sometimes be perceived negatively by the market.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, such as this director's sale, are routinely disclosed for transparency but do not inherently indicate broader industry trends. Such sales are often part of pre-arranged financial planning, especially when executed under a Rule 10b5-1 plan, which aims to mitigate concerns about trading on material non-public information.

Stakeholder Impact

• Shareholders: May observe a director selling shares, which could be interpreted in various ways depending on individual investment strategies and the context of the sale (e.g., 10b5-1 plan).

Key Dates

Recommendation

The filing reports a director's sale of shares under a Rule 10b5-1 plan. Such pre-scheduled sales are common for financial planning and do not typically indicate a change in the company's fundamental outlook or warrant a strong buy/sell recommendation based solely on this information. Investors should consider this as a routine disclosure and maintain their current position while monitoring broader company performance and market conditions.

Keywords

Universal Corp, UVV, Insider Trading, Form 4, Stock Sale, Director, Lennart R. Freeman, Equity Transaction, SEC Filing, 10b5-1 Plan